Skip to main
MYO
MYO logo

Myomo (MYO) Stock Forecast & Price Target

Myomo (MYO) Analyst Ratings

Based on 8 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Myomo Inc. demonstrated impressive financial performance, reporting record quarterly revenues of $12.1 million, a 154% increase year-over-year and surpassing consensus estimates significantly. The company's strong revenue growth was bolstered by an increased average selling price driven by a higher volume of Medicare patients, alongside a 106% year-over-year rise in total revenue units, contributing to optimistic projections of total revenue reaching $52.3 million in 2025. Additionally, Myomo's gross margin improved to 71%, a notable increase from 65% in the previous quarter, while adding 657 new patient candidates to its pipeline, reflecting strong operational momentum in the growing myoelectric orthotics market.

Bears say

Myomo Inc. faces a declining backlog of insurance-authorized orders, decreasing from 316 in the previous quarter to 272, which raises concerns about future revenue generation. The company reported a net loss of $0.01 per share, which, although slightly better than analyst expectations of a $0.02 loss, still highlights ongoing financial challenges and operational inefficiencies. Additionally, several fundamental risks, including liquidity issues, regulatory hurdles, and competition in the healthcare market, contribute to a negative outlook for the stock, suggesting that the potential for growth may not suffice to outweigh these substantial concerns.

Myomo (MYO) has been analyzed by 8 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Myomo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Myomo (MYO) Forecast

Analysts have given Myomo (MYO) a Strong Buy based on their latest research and market trends.

According to 8 analysts, Myomo (MYO) has a Strong Buy consensus rating as of Sep 9, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $6.96, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $6.96, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Myomo (MYO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.